Lael M Yonker Selected Research

Lael M Yonker Research Topics

Disease

27	COVID-19 04/2024 - 11/2020
19	Infections 04/2024 - 02/2015
12	Cystic Fibrosis (Mucoviscidosis) 01/2024 - 12/2017
7	COVID-19 related pediatric multisystem inflammatory disease 11/2022 - 10/2020
4	Inflammation (Inflammations) 10/2021 - 10/2017
2	Myocarditis (Carditis) 12/2023 - 01/2023
2	Human Influenza (Influenza) 01/2021 - 12/2020
2	Septic Shock (Toxic Shock Syndrome) 01/2021 - 11/2020
1	Hyperglycemia 01/2024
1	Neoplasms (Cancer) 08/2023
1	Chest Pain (Chest Pains) 01/2023
1	Exanthema (Rash) 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Breakthrough Infections 12/2022
1	Whooping Cough (Pertussis) 01/2021
1	Acute Disease 01/2021
1	Viremia 12/2020
1	Persistent Infection 01/2018
1	Pseudomonas Infections 12/2017
1	Lung Diseases (Lung Disease) 01/2012

Drug/Important Bio-Agent (IBA)

8	mRNA VaccinesIBA 04/2024 - 01/2021
8	VaccinesIBA 12/2022 - 01/2021
7	Messenger RNA (mRNA)IBA 01/2024 - 01/2021
7	AntibodiesIBA 12/2023 - 12/2020
6	Immunoglobulin G (IgG)IBA 04/2024 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2021
3	AntigensIBA 01/2023 - 12/2021
3	InterferonsIBA 12/2022 - 10/2021
3	EicosanoidsIBA 01/2021 - 02/2015
3	8- hydroxy- 11,12- epoxyeicosa- 5,9,14- trienoic acidIBA 10/2017 - 02/2015
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2024 - 12/2021
2	Immunoglobulin A (IgA)IBA 04/2024 - 08/2023
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2022
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2023 - 03/2018
2	CytokinesIBA 10/2023 - 01/2023
2	zonulinIBA 02/2022 - 01/2021
2	Fc Receptors (Fc Receptor)IBA 10/2021 - 03/2021
2	Interleukin-10 (Interleukin 10)IBA 10/2021 - 03/2021
2	Complement System Proteins (Complement)IBA 10/2021 - 01/2021
2	SuperantigensIBA 01/2021 - 11/2020
1	Advanced Glycation End ProductsIBA 01/2024
1	Neutralizing AntibodiesIBA 12/2023
1	Immunoglobulin M (IgM)IBA 10/2023
1	Immunoglobulins (Immunoglobulin)IBA 08/2023
1	tezacaftorIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	ChloridesIBA 01/2023
1	ivacaftor drug combination tezacaftorIBA 01/2023
1	elexacaftorIBA 01/2023
1	Troponin T (Troponin T1)IBA 01/2023
1	2019-nCoV Vaccine mRNA-1273IBA 11/2022
1	AmphiregulinIBA 11/2022
1	larazotide acetateIBA 02/2022
1	Antiviral Agents (Antivirals)IBA 10/2021
1	EndocannabinoidsIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	AerosolsIBA 01/2021
1	EnzymesIBA 01/2021
1	Hemagglutinins (Hemagglutinin)IBA 12/2020
1	Angiotensin-Converting Enzyme 2IBA 12/2020
1	Serine Proteases (Serine Protease)IBA 12/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Pepsin A (Pepsin)IBA 01/2019
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2018
1	Virulence Factors (Pathogenicity Factors)IBA 01/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 12/2017
1	FumaratesIBA 12/2017
1	AminoglycosidesIBA 12/2017
1	Tobramycin (Nebcin)FDA LinkGeneric 12/2017
1	Leukotriene B4IBA 10/2017
1	Chemotactic FactorsIBA 10/2017
1	LipidsIBA 10/2017

Therapy/Procedure

8	Therapeutics 11/2023 - 01/2012
4	Palliative Care (Palliative Therapy) 11/2023 - 01/2018
1	Drug Therapy (Chemotherapy) 08/2023